Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$951M |
| 2 |
Advanced Micro Devices
AMD
|
+$589M |
| 3 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$418M |
| 4 |
Lam Research
LRCX
|
+$412M |
| 5 |
Microsoft
MSFT
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$1.24B |
| 2 |
Apple
AAPL
|
+$585M |
| 3 |
STMP
Stamps.com, Inc.
STMP
|
+$111M |
| 4 |
HRC
HILL-ROM HOLDINGS, INC.
HRC
|
+$87.8M |
| 5 |
TSMC
TSM
|
+$70.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.05% |
| 2 | Financials | 11.79% |
| 3 | Healthcare | 10.9% |
| 4 | Consumer Discretionary | 10.36% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
W.P. Carey
WPC
$16.4B
| $459K | ﹤0.01% |
6,420
+580
| +10% | +$44.1K |
|
652
Truist Financial
TFC
$64.2B
| $458K | ﹤0.01% |
7,810
+1,263
| +19% | +$70.6K |
|
653
Dow Inc
DOW
$21.9B
| $457K | ﹤0.01% |
7,935
+128
| +2% | +$7.83K |
|
654
Allstate
ALL
$69.6B
| $455K | ﹤0.01% |
3,576
-61
| -2% | -$8.06K |
|
655
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
| $453K | ﹤0.01% |
3,986
| – | – |
|
656
iShares MSCI Taiwan ETF
EWT
$10.6B
| $451K | ﹤0.01% |
7,276
+452
| +7% | +$28.8K |
|
657
Globe Life
GL
$14.4B
| $449K | ﹤0.01% |
5,046
-230
| -4% | -$21.5K |
|
658
iShares Russell 2000 ETF
IWM
$82.1B
| $443K | ﹤0.01% |
2,023
-1,871
| -48% | -$415K |
|
659
Delta Air Lines
DAL
$60.5B
| $442K | ﹤0.01% |
10,383
-989
| -9% | -$40.4K |
|
660
Cincinnati Financial
CINF
$27.5B
| $435K | ﹤0.01% |
3,805
+318
| +9% | +$37.7K |
|
661
iShares Core S&P Mid-Cap ETF
IJH
$125B
| $434K | ﹤0.01% |
+8,240
| New | +$443K |
|
662
iShares Global Materials ETF
MXI
$355M
| $434K | ﹤0.01% |
5,093
+122
| +2% | +$11.1K |
|
663
Xcel Energy
XEL
$48.1B
| $428K | ﹤0.01% |
6,852
+640
| +10% | +$43.2K |
|
664
UBS Group
UBS
$173B
| $420K | ﹤0.01% |
26,370
-5,563
| -17% | -$90.1K |
|
665
iShares MSCI EAFE Growth ETF
EFG
$17B
| $419K | ﹤0.01% |
3,938
+648
| +20% | +$71.3K |
|
666
Phillips 66
PSX
$82B
| $419K | ﹤0.01% |
5,977
+1,493
| +33% | +$108K |
|
|
IBHC
667
DELISTED
iShares iBonds 2023 Term High Yield and Income ETF
IBHC
| $418K | ﹤0.01% |
+16,945
| New | +$418K |
|
668
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.91B
| $414K | ﹤0.01% |
3,788
-10,780
| -74% | -$1.18M |
|
669
Automatic Data Processing
ADP
$109B
| $410K | ﹤0.01% |
2,051
+94
| +5% | +$19.4K |
|
670
Vanguard Consumer Discretionary ETF
VCR
$6.24B
| $409K | ﹤0.01% |
1,318
-135
| -9% | -$42.9K |
|
671
Accenture
ACN
$105B
| $406K | ﹤0.01% |
1,268
-191
| -13% | -$62.1K |
|
672
Collegium Pharmaceutical
COLL
$944M
| $402K | ﹤0.01% |
20,349
+5,254
| +35% | +$114K |
|
673
Paychex
PAYX
$42.7B
| $402K | ﹤0.01% |
3,576
+1,126
| +46% | +$126K |
|
674
iShares Russell 1000 Value ETF
IWD
$83.2B
| $401K | ﹤0.01% |
2,564
-959
| -27% | -$154K |
|
675
Yum! Brands
YUM
$41.6B
| $401K | ﹤0.01% |
3,276
+273
| +9% | +$34.6K |
|
Similar funds
Ken Fisher's Q3 2021 Portfolio in Review
As of Q3 2021, Ken Fisher held 1,103 positions worth $161B, up 1.1% from $159B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Fisher's Q3 2021 filing shows 93 new, 444 increased, 375 reduced and 75 closed positions. Its largest new stake was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M. The largest sale was Visa, an estimated $1.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q3 2021 buy was Biohaven Pharmaceutical Holding Company Ltd.: 267,976 shares worth $37.2M.
- Ken Fisher added most to Meta Platforms (Facebook) in Q3 2021, an estimated $951M increase.
- Ken Fisher's biggest Q3 2021 reduction was Visa, cutting an estimated $1.24B.
- Ken Fisher fully exited Stamps.com, Inc. in Q3 2021, selling an estimated $111M.
- Ken Fisher's ten largest holdings make up 31% of its $161B portfolio in Q3 2021.
- Ken Fisher opened 93 new positions and closed 75 in Q3 2021.
- Ken Fisher's portfolio value rose 1.1% quarter-over-quarter to $161B.
Based on Fisher Asset Management's 13F filing for Q3 2021, filed 26 Oct 2021.